3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
3
Melanoma
2
Carcinoma, Transitional Cell
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Incontinence
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Esophageal Neoplasms
1
Erectile Dysfunction
1
Desmoid Tumors
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Sildenafil Citrate
8
Tadalafil
2
Surveys and Questionnaires
2
Alprostadil
2
udenafil
1
trametinib
1
sotorasib
1
selpercatinib
1
pembrolizumab
1
osimertinib
1
mirabegron
1
methyl 3-mercaptopropionimidate
1
lorlatinib
1
dabrafenib
1
cemiplimab
1
brigatinib
1
bicalutamide
1
alpha-Tocopherol
1
alectinib
1
Vitamin E
1
Tamoxifen
1
Surgical Instruments
1
Saline Solution
1
Restraint, Physical
1
Psychiatric Rehabilitation
1
Preservation, Biological
1
Pentoxifylline
1
Pemetrexed
1
Paclitaxel
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Erectile Dysfunction
×
High-Intensity Focused Ultrasound Ablation
×
Clear all
NCT01194648
2018-04-20
INDEX
University College, London
Phase NA
Recruiting
354 enrolled